Searched for
BASALOG ONE
Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma giantsSanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licens...- Biocon Q2 net profit jumps 3-fold at Rs 306 croreThe consolidated revenue of Biocon was up by 11.38 per cent at Rs 861 crore during the quarter compared to Rs 773 crore in the year-ago per...
- Biocon opens facility to produce devices for insulin portfolioSpread over 10,000 square feet, the facility will manufacture pen like delivery devices for people with diabetes in India and other parts o...
- Biocon joins hands with US co Amylin for diabetes drugBiocon has put the development of its diabetes drug on the fast track by teaming up with US-based biopharma player Amylin Pharmaceuticals.
- 'Basalog does not come under NPPA purview, NPPA should make the correction'Biocon’s CMD Kiran Mazumdar Shaw is betting big on the oral insulin drug that the company is scheduled to unveil next March. She said the f...
Load More- Biocon joins hands with US co Amylin for diabetes drug